KOMBINATIONSTUMORIMMUNTHERAPIE

European patent · EP3240801 · In force

Register entry

Publication number
EP3240801
Application number
EP15876030
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 22, 2015
Published
Nov 8, 2017
Granted
Jan 20, 2021
Protection ends at the latest
Dec 21, 2035
Next annual fee due
Dec 31, 2026
IPC classes
A61K 31/7125 (2006.01)
C07K 14/56 (2006.01)
A61P 35/00 (2006.01)
C07K 16/28 (2006.01)
Priority
US 201462098568 P 31.12.2014
US 201562106526 P 22.01.2015
US 201562118165 P 19.02.2015
PCT application
PCT/US2015/067269 22.12.2015
PCT publication
WO2016/109310 07.07.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 9, 2026

    Agent removed

    Representative
    TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly (removed)

    Published in Swissreg on 09.04.2026

  2. Apr 9, 2026

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 09.04.2026

  3. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  4. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  5. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  6. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  7. Dec 1, 2021

    Change

    Published in Swissreg on 01.12.2021

  8. Feb 5, 2021

    Agent entered

    Representative
    TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly

    Published in Swissreg on 05.02.2021

1 earlier entry
  1. Jan 20, 2021

    Granted

    Published in Swissreg on 20.01.2021

Parties

Inventor

KRIEG, Arthur, M.

Cambridge, MA 02138, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.